Third World Research Can Present `Unimaginable' Problems

University of Iowa biochemist John Donelson's brush with disaster during a 1987 expedition to West Africa is a prime example of the kind of nightmare that can occur when a scientist embarks on a research project in a Third World country. For weeks Donelson had been touring remote areas in Mali and Cameroon, collecting parasite specimens from natives infected with onchocerciasis, a disease prevalent in sub-Saharan Africa. Midway through the Cameroon leg of his trip, Donelson ran low on the liqui

Written byLisa Holland
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

Hasty inquiries uncovered only a single source of liquid nitrogen in the entire country, but the facility was no longer functioning. Just when things looked utterly hopeless, one of the Cameroonian scientists who had accompanied Donelson into the field salvaged the situation. After several days of negotiation, Donelson's colleague talked the owner of the facility into making enough repairs to produce a few liters of liquid nitrogen. This amount proved sufficient to see Donelson through to the end of the expedition and to transport the specimens back to the United States for further study.

With the war in the Persian Gulf intensifying United States citizens' fears of terrorism while traveling abroad, scientists should remember that performing research in certain parts of the world can entail a degree of danger. Of course, the entire Third World is not a uniform hotbed of unrest and violence, although it is sometimes portrayed otherwise. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies